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A b s t r a c t
Angiocentric glioma (AG) is a newly-classified, very rare, WHO grade I central nervous system (CNS) lesion, occurring 
usually in children and young adults. Only 52 patients with AG have been reported so far, making it one of the rarest 
neuropathological entities. Hereby we present two new cases of AG in young subjects with detailed neuropatholog-
ical investigations and a neuroradiological picture along with a brief summary of all already published literature 
reports of this tumor. 
Histopathological examination of the resected tissue from both cases revealed similar changes characteristic of AG. 
The tumors were composed of spindle-like, elongated cells, forming characteristic pseudorosettes around vessels and 
diffusively infiltrating surrounding tissue, trapping neurons between tumor cells. Noticeably, some neoplastic cells 
encrusting vessels extended far beyond the main tumor mass. Hypothetically, this may be responsible for the recur-
rence of the tumor even in the case of apparently total excision. In immunohistochemistry, AG cells were glial fibril-
lary acidic protein (GFAP) and vimentin positive, also exhibiting a strikingly significant epithelial membrane antigen 
(EMA) dot-like staining pattern. In one of the cases, electron microscopy revealed ependymal differentiation features 
such as microvilli and cilia. Taken together, all these data strongly confirm a dual astroglial-ependymal nature of 
the tumor. Follow up corroborates benign character of this neoplasm. Both AGs reported here were immunonegative 
for the product of the mutated IDH-1 gene what, according to our best knowledge, has never been reported so far. 
It may suggest that in their pathogenesis AGs differ from grade II astrocytomas, which in most cases harbor a muta-
tion of IDH-1. Noteworthy, neuroimaging in our cases was relatively characteristic but not conclusive, therefore biopsy 
(at least) is mandatory. A newly proposed so called “A-B-C” classification of long-term epilepsy-associated tumors 
(LEATs) places AG in a category named ANET. The authors shortly review the A-B-C classification of LEATs.
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Introduction
Angiocentric glioma (AG) is a very rare low-grade 
neoplasm, mainly affecting children and young 
adults. So far, to our best knowledge only 52 cases 
have been reported, with first literature reports dat-
ing back to 2005, when two different cases of cen-
tral nervous system (CNS) lesions were described 
as a  new pathological entity, due to their specific 
magnetic resonance imaging (MRI) appearance and 
glial and ependymal differentiation in histopatho-
logical examination [11,29]. Those findings were 
included in the 2007 World Health Organization 
(WHO) Classification of Tumours of the Central Ner-
vous System, which classified AG as WHO I  grade 
tumor [14]. Angiocentric glioma occurs in a  broad 
age range, varying from 2 to 70 years of age, how-
ever it seems to affect more frequently children and 
young adults. Angiocentric glioma grows predom-
inantly in supratentorial locations, usually in fron-
tal and temporal cortex, however there are cases 
of lesions localized in mid-brain, amygdalae and 
hippocampus [13,17,19,23]. A typical symptom of AG 
is drug-resistant epilepsy. Some patients suffer also 
from headaches and vision impairments. In MRI 
examination, AG forms a  well-demarcated lesion, 
hyperintense on T2 and hypointense on T1-weighted 
image, with “stalk-like” protrusions towards ventri-
cle [11]. Calcifications are only rarely observed [24]. 
Most common treatment is surgical resection, which 
seems to be the most beneficial for the patients. In 
histopathological examination, tumor tissue exhib-
its a very characteristic growth pattern, in its most 
typical form composed of elongated, spindle like 
cells, arranged radially and longitudinally around 
vessels and forming palisade-like structures under 
pia. Angiocentric glioma cells exhibit a low prolifera-
tive rate, with reported labeling Ki-67 (MIB-1) indices 
ranging from 1 to 5%, what corroborates with benign 
clinical behavior observed in these tumors [12]. Not-
withstanding some cases with higher mitotic rates 
were also reported [12,22]. In AG one can observe 
traits of both astroglial and ependymal-originated 
cells, what may suggest an origin from a hypothet-
ical common progenitor cell. Angiocentric glioma 
proves to be a challenge, as the main symptom i.e. 
drug-resistant epilepsy and its complications e.g. 
cranial trauma can be misleading in the diagnostic 
process. Predilection to frontal and temporal cortex is 
also troublesome, therefore surgical resections need 
to be performed with extra caution, best – using 
neuronavigation methods, with the help of fMRI and 
diffusion tensor imaging (fibertracking). Due to rel-
atively scarce information about the clinical course, 
optimal methods of treatment, and prognosis, every 
piece of information is valuable to establish valid, 
evidence-based methods of handling this condition. 
In this study, we present 2 cases of young patients 
with AG and a thorough functional and radiological 
examination, performed before the surgery.
Material and methods
Case 1
A girl aged 11 years was admitted to the region-
al hospital after an episode of generalized seizu res. 
Electroencephalography (EEG) and MRI were per form-
ed. Electroencephalography examination revealed an 
abnormal pattern with numerous seizure spikes, reg-
istered bilaterally over frontal lobes, with the predom-
inance of the left frontal lobe and the tendency of 
generalization. Magnetic resonance imaging revealed 
a T1 hypointense, T2 hyperintense lesion located in 
the left frontal lobe (Fig. 1A-E), sized 25 × 35 × 45 mm. 
The patient was transferred to the University Chil-
dren’s Hospital in Krakow with a diagnosis of brain 
tumor. Due to the vital site of the change (proximity 
to left motor and sensory cortex), additional methods 
of imaging: fMRI and tractography were performed 
to minimize the risk of collateral damage. Gross total 
resection of the tumor was achieved, the patient 
was released home with no signs of focal brain inju-
ry. During 16 months’ post-operative period, neither 
further seizures nor other symptoms of tumor recur-
rence were noted.
Case 2
A male aged 25 years with no previous history 
of any health problems was admitted to the hospi-
tal after 3 episodes of seizures. As a  result of the 
last epileptic episode, the patient suffered from 
facial trauma. In neurological examination, no signs 
of focal brain injury have been found. Computed 
tomography (CT) revealed a hyperdensive, well-de-
marcated mass, size of 21 × 8 mm, located in the left 
frontal lobe. The mass was surrounded by a zone of 
grade I edema. The ventricular system of the brain 
showed no pathological changes. Initially, the lesion 
was interpreted as a hemorrhagic focus of brain con-
cussion. Due to the unknown origin of the two initial 
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Fig. 1. Magnetic resonance imaging. Case No 1. A) Partially hyperintense cortically based lesion in the 
left frontal lobe. MRI; axial plain; FLAIR sequence. B) Hyperintense lesion with stalk-like extension toward  
the ventricle. MRI; axial plain; frFSET2 sequence. C) No evidence of restriction diffusion inside the lesion. 
MRI; axial plain; DWI sequence. D) Ribbon-like hyperintense rim. MRI; axial plain; SET1 sequence. E) No 
enhancement inside the tumor. MRI; axial plain; postcontrast SET1. F) Case No 2. Slightly bubbly hyperin-
tense lesion in the frontal lobe, without evidence of expansion. MRI; axial plain; frFSET2. 
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seizures, the patient was qualified for MRI, which 
showed T2 hyperintense, T1 hypointense mass, 
located in the left frontal lobe, forming a cone-like 
structure (Fig. 1F), sized about 25 × 15 × 30 mm rang-
ing from the pia up to 5 mm distance from the left 
lateral ventricle. The patient showed no neurological 
or neuropsychological abnormality. Left frontal cra-
niotomy revealed a widened brain lobule, containing 
the whole mass of the tumor. The lesion was dis-
sected with the help of neuronavigation based on 
brain MRI. Neurological status of the patient after 
the surgery did not deteriorate. On the seventh day 
after the surgery one episode of seizures was noted. 
During 40 months’ follow-up repeated MRI and EEG 
excluded the recurrence of the tumor. Also no fur-
ther seizures were observed.
Results
In both presented cases, histopathological and 
immunohistochemical examination of the resect-
ed tissue revealed an identical pattern (summary 
of immunohistochemical methods applied given in 
Table I). The tumors were composed of elongated 
cells (Fig. 2A), characteristically surrounding vessels 
and forming pseudorosette structures around them 
(Fig. 2B, C). A  few delicate perivascular accumula-
tions of glioma cells extended to some distance out 
of the main tumor mass (Fig. 2D). Tumor cells, adja-
cent to pia created a  conspicuous palisading pat-
tern (Fig. 2A). Inside of the tumor tissue, there were 
remaining Neu-N positive neurons, some of them 
trapped between AG cells, which all were immu-
nonegative for Neu-N (Fig. 2E). Tumor cells were neg-
ative for synaptophysin, what contrasted with syn-
aptophysin-positive neuropil background (Fig. 2F). 
Glioma cells were strongly immunopositive for 
GFAP, what indicates their astrocytic differentiation 
(Fig. 2G), noticeably showing conspicuous dot-like 
positivity for EMA, which is regarded as a signature 
of ependymoma (Fig. 2H). Ependymal traits were fur-
ther confirmed by electron microscopy, which showed 
numerous microvilli, tight junctions and cilia (Fig. 2I) 
(electron microscopy was performed only in Case 1). 
In both cases tumor cells were strongly positive for 
vimentin and totally negative for cytokeratins (AE1/
AE3). Moreover, both cases were immunohistochem-
ically negative for mutated product of the isocitrate 
dehydrogenase (IDH-1) gene. Mitoses were absent 
and only exceptionally, single Ki-67 immunopositive 
nuclei were seen. Taken together, in both cases the 
morphological features and the pattern of immuno-
expression were pathognomonic for AG.
Discussion
Considering many factors such as age, gender, 
localization and symptomatology of the disease, 
both cases present a  typical course of AG. In the 
published cases (summarized in Table II), mean age 
of diagnosis was almost 18 years (mean = 17.7, 
SD = 16). So far, AG has been presented in 23 female 
and 29 male patients (total number: 52). Reported 
cases were located in temporal lobes (20 cases, 
Table I. Summary of immunohistochemistry
Name Company Dillution Unmasking Incubation time Detection
GFAP DAKO 1/50 EDTA 30 min EnVision
EMA DAKO 1/100 – 30 min EnVision
CD34 DAKO 1/50 Citrate buffer 60 min EnVision
S-100 DAKO 1/400 – 30 min EnVision
Vim DAKO Ready to use – 30 min EnVision
AE1/AE3 DAKO 1/50 Proteinase 30 min EnVision
Ki-67 DAKO 25-Jan EDTA 24 h EnVision
Neu-N Millipore 1/100 Citrate buffer 24 h UltraVision HRP 
Polymer
Synaptophysine DAKO 20-Jan EDTA 30 min Envision
IDH-1 Dianova 1/100 Citrate buffer 30 min UltraVision HRP 
Polymer
44 Folia Neuropathologica 2016; 54/1
Dariusz Adamek, Grzegorz Przemysław Siwek, Adrian Andrzej Chrobak, Izabela Herman-Sucharska, Stanisław Kwiatkowski, Rafał Morga,  
Edyta Radwańska, Barbara Urbanowicz
out of which 6 in hippocampus and 6 in amyg-
dala), frontal lobes (18), parietal lobes (13), occip-
ital lobes (5), insula (2) brainstem (1), thalamus 
(1) (the numbers do not add up to a  total of 52, 
since in some reports locations overlap more than 
1 lobe). 40/52 patients presented seizures which 
can be regarded as the most typical symptom of 
this tumor. Only a  few patients suffered from focal 
neurological symptoms. Accordingly, in both present-
ed cases the most prominent symptoms were also 
seizures, resistant to typical anti-epileptic treatment. 
In case 1 MRI has shown a  well-demarcated lesion, 
with no signs of the mass effect (Fig. 1A-E). In case 2 
the correct diagnosis was hindered by radiologi-
cal signs of brain contusion, caused by trauma in 
the course of epileptic seizures. Consecutively MRI 
imaging revealed a  lesion, suggestive of a  benign/
low-malignant tumor (Fig. 1F). According to WHO 
2007 Classification of Tumours of the Central Nervous 
System, major differential diagnosis in the case of 
a well-delineated cortically based lesion in the frontal 
lobe in children with epilepsy is angiocentric glioma, 
oligo dendroglioma, dysembryoplastic neuroepithelial 
tumor (DNT) and ganglioglioma [21]. Dysembryoplastic 
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Fig. 2. Angiocentric glioma. Tumor outgrowth within the cortex, reaches pia, where it forms a palisade-like 
pattern (A) and characteristic pseudorosettes around vessels (B). Perivascular arrangement is well observed 
in a slide stained immunohistochemically for CD34 – marker of endothelial cells (C). Some vessels encrust-
ed with single bona fide glioma cells (D, see arrows) extend relatively far away from the main tumor mass 
(D). Within the invaded cortex, there are still numerous remaining neurons (E). Synaptophysin-negative 
tumor cells contrast strongly with positive neuropil background (F). Cells show strong immunopositivity 
for GFAP (G) and dot-like immunopositivity for EMA (H). Electron microscopy revealed numerous microvilli  
(i, asterisk), cilia (i, marked with a quadrangle and enlarged in the inset), and tight junctions (i, arrowhead). 
Methods applied: A, B, D – hematoxylin-eosin, C – CD34, E – Neu-N, F – synaptophysin, G – GFAP, H – EMA 
immunostaining, I – electron microscopy. Case 1 represented in: A, C, E, F, G, I, case 2 represented in: B, D, H.
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Table II. Summary of the reported cases of AG
Authors Year Age of 
diagnosis
Gender Localisation Symptoms
Alexandru et al. 2013 12 F Left frontotemporal Seizures
Lu et al. 2013 15 M Right frontal Progressive left-sided weakness 
+ headache
Aguilar et al. 2012 15 M Right anterior frontal Progressive left-sided weakness 
+ umbness
Liu et al. 2012 14 M Right posterior inferior 
temporal
Seizures
22 M Left temporal + amygdala + 
hippocampus
Seizures
13 F Anterior temporal + amygdala Seizures
Koral et al. 2012 4 M Right temporal Development and speech delay
Grajkowska et al. 2011 15 F Right temporal Seizures
14 M Left occipito-parietal Seizures
Miyahara et al. 2011 66 F Right insula Seizures
Takada et al. 2011 26 M Right superior frontal Seizures
Miyata et al. 2012 54 F Left hippocampus + amygdala Seizures
37 M Left uncus + amygdala Seizures
Rho et al. 2011 10 F Right medial frontal Dizziness, otalgia, nystagmus
Marburger et al. 2011 10 F Left parieto-occipital Seizures
15 M Left temporal + amygdala + 
hippocampus
Seizures
19 M Left parietal Seizures
3 F Left temporal + amygdala + 
hippocampus
Seizures
15 M Right thalamus Headache + visual disturbances
Pokharel et al. 2011 3 M Right posterior parietal Seizures
Hu et al. 2010 19 M Left frontal Dizziness
Mott et al. 2010 57 F Right frontal Seizures, left hand tremor, 
headaches
Shakur et al. 2009 13 F Left anterior temporal Seizures + headaches
10 M Left posterior temporal Hearing impairment, shortening 
attention span
10 M Left middle temporal Seizures
Covington et al. 2009 5 F Exophytic on brainstem Severe cranial neuropathy + gait 
disturbance
Fulton et al. 2009 2 M Right frontoparietal Seizures
Lum et al. 2008 5 M Right frontal Seizures
Sugita et al. 2008 6 M Right occipitoparietal Seizures
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neuroepithelial tumor has more “bubbly” appearance 
on T2w images. Oligodendroglioma is a  gray-white 
matter interface originated mass. Angiocentric glio-
ma typically expands gyri, creates T1w hyperintense 
rim and stalk-like extension toward the ventricle [11]. 
The clue in proper diagnosis of this tumor may also 
be intrinsic ribbon-like T1 shortening [10]. Ganglio-
gliomas often enhance, while angiocentric gliomas 
do not. The most typical findings of angiocentric gli-
oma are presented in Case 1. 
In Case 1 the operation was performed with 
the help of the neuronavigation, thus reducing the 
risk of complications. In this case, during so far 16 
months’ follow-up, no epileptic seizures have been 
observed, what is consistent with a  typical course 
of the disease, according to the literature. In case 2, 
only one episode of the seizures was observed soon 
after surgery, but there were no seizures in the fol-
low-up (42 months). One may speculate that this 
single episode of seizures reflected rather a  side 
effect of post-operation damage, than the result of 
residual tumor tissue. Neuropathological investiga-
tion of resected tumors have shown a common char-
acteristic picture of AG with especially conspicuous 
perivascular crowding of cells, subpial palisading, 
and a typical immunohistochemical staining pattern 
indicating shared astrocytic and ependymal proper-
ties of tumor cells. 
Authors Year Age of 
diagnosis
Gender Localisation Symptoms
Preusser et al. 2007 15 M Precuneus Seizures
6 M Medial temporal Seizures
17 M Frontoparietal Psychomotor disturbance
9 F Medial inferior temporal Psychomotor disturbance
37 F Hippocampus Seizures
70 F Hippocampus Psychomotor disturbance
35 M Parietal Psychomotor disturbance
15 F Precuneus Seizures
Wang et al. 2005 3 M Left occipital Seizures
14 M Right inferior frontal Seizures
3 F Left occipital Seizures
4 F Right parietal Seizures
30 F Left anterior temporal Seizures
26 M Left frontal Seizures
37 M Right frontal Seizures
15 F Right medial temporal Seizures
Lellouch-Tubiana et al. 2005 2 M Right frontoparietal Seizures
4.5 M Right parietal Seizures
6.5 M Left frontoparietal Seizures
3 F Left frontal Seizures
4 F Left medial temporal Seizures
9.5 F Left frontal Seizures
13 F Right orbitofrontal, gyrus 
rectus, insula
Seizures
Table II. Cont.
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In histopathological differential diagnosis of this 
tumor one needs to include low-grade neoplasms, 
such as DNT, which also occurs in children and 
manifests clinically by seizures. Literature theoret-
ically indicates focal cortical dysplasia, low-grade 
astrocytoma [22], ependymoma, astroblastoma and 
papillary glioneuronal tumor, and even also subep-
endymoma, pilocytic astrocytoma, and ganglion cell 
tumor as candidates for differential diagnosis [3]. 
The presence of tumor cells in distant regions from 
the original mass should be also noted, as it might 
contribute to the observed tendency for recurrence 
of this tumor. Neurosurgeons might contribute to 
these data, while planning secondary resection of 
the recurring tumor by further enlarging the opera-
tion area in proximity of the vessels.
In practice the most important options of differen-
tial diagnosis encompass astroblastoma, ependymo-
ma and (less importantly) papillary glioneuronal tumor. 
Given the twofold nature of AG (features of both 
glial and ependymal cells), it is plausible that the 
tumor itself could originate from the early progenitor 
cell. There are scarce data concerning pathophysiolo-
gy of this tumor. In electron microscopy AGs exhibit 
signs of ependymal differentiation (microvilli, cilia, 
tight junctions) [29]. A  diffuse infiltration pattern 
along with presence of immunopositivity for S100, 
GFAP, and vimentin is consistent with the glial (espe-
cially astrocytic) character of the tumor. Immunoneg-
ativity for synaptophysin and Neu-N helps to exclude 
the papillary glioneuronal tumor. The differentiation 
of AG with astroblastoma and ependymoma is more 
troublesome. Ependymoma (apart from the different 
location in most cases) microscopically seems to pres-
ent with more slender cell nuclei and less distinct cell 
boundaries, and reactivity for GFAP also seems to be 
less pronounced than in AG. Even more disputable is 
to set guidelines for differentiation between AG and 
astroblastoma, since among others, an electromicro-
scopic picture may be similar to that of AG. Probably, 
the most helpful clue, speaking in favor of astroblas-
toma is the lack of subpial palisading and presence of 
vascular sclerosis and hyalinization [3]. Regarding its 
cellular composition AG, in contrast to diffuse astro-
cytoma, is much more monomorphic [16]. In most cas-
es of AG, a low mitotic count is observed. However, if 
a high mitotic count is present it does not alter the 
benign character of growth [22]. 
According to new proposals of Blumcke et al., 
angiocentric gliomas make a  separate entity (so 
called angiocentric neuroepithelial tumor – ANET), 
included in the group of tumors characteristically 
related to epilepsy and hence accordingly named 
“long-term epilepsy associated tumors” (LEATs). 
“Long-term epilepsy associated tumors” incorpo-
rate a large variety of neuronal and glial tumors that 
are encountered in patients, surgically treated for 
a  long-time epilepsy (over 2 years). Typically, LEATs 
are benign tumors with presence of the neuronal 
component and predilection to neocortical regions, 
especially temporal lobes. They tend to acquire their 
epileptogenic potential in young age, thus in most 
cases, first symptoms of these neoplasms are focal 
seizures. “Long-term epilepsy associated tumors” 
present slow growth rates, therefore the prognosis 
for the patients, even without the radical surgery, are 
generally very good. However in a number of cases, 
progression of seizures or even anaplastic transfor-
mation to higher WHO grades have been observed 
[28]. Blumcke et al. proposed a new approach to diag-
nosing and treatment of a  group of these tumors. 
This approach is applicable for both clinicians (that 
are responsible for weighing the risk and gains from 
surgery) and neuropathologists. While in the case 
of adult and elderly patients, diagnosis of a  brain 
tumor is usually followed by the resection of the 
lesion, in LEATs patients this might not be the only 
conceivable way of proceeding. Children and young 
adults with the lesions located in typical locations for 
LEATs (e.g. temporal lobes) could be managed dif-
ferently. At first, careful examination with the help 
of experienced neuroradiologists is mandatory. Due 
to a  slow growth rate and benign behavior of the 
tumor, pharmacological treatment is to be introduced 
to achieve seizure control, however bearing in mind 
the adverse long-term effects of medication and 
impact of uncontrolled seizures on patients’ cogni-
tion. When this option turns to be ineffective, surgical 
resection is advocated. During the surgery, one has to 
bear in mind that some types of LEATs tend to infil-
trate the radiologically-unchanged tissue, therefore 
in a non-dominant lobe, gross resection of the tumor 
including adjacent tissues is advised. If the tumor is 
localized in the dominant lobe or in close proximity 
to vital brain regions, invasive electrocorticography 
is strongly advised to limit the damage, while allow-
ing to achieve the best available effect. Regarding 
pathological examination of the lesion, Blumcke et al. 
proposed a new A-B-C classification of epilepsy-as-
sociated tumors, that is focused on immunochem-
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istry markers (MAP2, CD34). In the case of AG, the 
authors proposed returning to the original term of 
“angiocentric neuroepithelial tumor” (ANET) [11]. 
Other items of A-B-C nomenclature include: BNET, 
CNET, DNET, ENET, GNET, INET. BNETs, regarded as 
“basic” oncofetal neuroepithelial tumors, are positive 
for CD34, and as for now are typically diagnosed as 
gangliogliomas. In contrast, CD34-negative tumors 
so far also typically diagnosed as gangliogliomas 
are named GNETs (“gangliocytic” neuroepithelial 
tumors). CNET and DNET refer to a complex (CNET), 
and simple (“typical”) respectively form of dysem-
bryoplastic neuroepithelial tumor (DNET = DNT). 
ENET, in turn, is a sort of an imprecisely defined cat-
egory for tumors, negative for CD34 (ENET standing 
for “epileptogenic NET not otherwise specified”). 
Lastly, INET is to be referred to tumors so far termed 
as “isomorphic astrocytomas” – a variant of diffuse 
astrocytoma, characterized by very low cellularity 
and strikingly uniformed, regular morphology. Sup-
posedly, though being diffused, they deserve rather 
WHO grade I than II [4].
Our results confirm the proposed diagnostic cri-
teria of ANET (as an equivalent of AG): tumor cells in 
both samples were CD34 and IDH-1 negative, EMA 
immuno-staining showed a dot-like pattern as well 
as palisade-like growth pattern around the vessel. 
The presence of tumor cells in distant regions from 
the original mass should be also noted, as it might 
contribute to the observed tendency for recurrence 
of this tumor. Neurosurgeons might contribute to 
these data, while planning secondary resection of 
the recurring tumor by further enlarging the opera-
tion area in proximity of the vessels.
There are attempts to characterize the genetic 
signature of AGs, Preusser et al. using comparative 
genetic hybridization did not find any specific gene 
marker for AG: genetic aberrations in tumor cells were 
sparse and heterogeneous, however in 1 out of 8 cas-
es a severe genetic imbalance was found. This aber-
ration was a  loss of chromosomal bands 6q24-q25. 
Imbalance on 6q is observed in many neoplasms, 
more interestingly, it has been described as fre-
quent in intracranial ependymomas. Preusser states 
that a potential candidate gene located on 6q24.1 is 
PLAGL1/ZAC1 gene, which is an important transcrip-
tion factor receptor, involved in regulation of the cell 
cycle and apoptosis. Even more interesting is that 
the features of neuronal degenerations (neurofibril-
lary tangles and Aβ plaques) in “trapped neurons” 
were found [23]. Vast majority of the cases presented 
a benign course of the disease – some patients with 
a history of the seizures counted in decades [20,23]. 
Despite that, supposedly malignant variants of AG 
(possibly WHO III), characterized by a higher mitotic 
index, vascular proliferation and necroses were also 
observed [1,15]. The elective method of treatment is 
gross total resection, but subtotal resection and che-
motherapy and radiotherapy had also been used, 
especially in more difficult locations or to handle rare, 
high grade variants [1,5,16,20]. One has to acknowl-
edge that the neuroradiological picture, though char-
acteristic, is not definitely specific therefore at least 
biopsy is mandatory. The aforementioned presence of 
tumor cells well beyond the main tumor mass speaks 
in favor of the necessity of gross total resection (if 
possible). This approach not only should lower the 
risk of recurrence, but also might be of importance 
in treatment of epilepsy. Prognosis after gross total 
resection is very good, with a low incidence of recur-
rence of the seizures in long-term follow up and only 2 
registered cases of death in the post-operative period 
[22]. According to Pokharel et al., thanks to the benign 
character of AG (confirmed by biopsy), some patients 
may live without the need of gross removal of tumor 
(radiotherapy only), what can be vital, especially 
for elderly patients [22]. New technologies like MRI, 
MRI-spectroscopy, diffusion tensor MRI have enabled 
neurosurgeons to limit collateral damage and precise-
ly remove even diffusely infiltrating AG masses thus 
eliminating the origin of epileptic seizures. Our obser-
vations indicate that the vessels surrounded by tumor 
cells extend relatively far away from the main tumor 
mass (Fig. 2D), and that implies the risk of regrowth 
even if such event happens relatively long after surgery. 
We have found both AGs reported here to be immu-
nonegative for the product of the mutated IDH-1 gene, 
which according to our best knowledge has never 
been reported so far. We are aware that it does not 
necessarily indicate a universal characteristic of AG, 
however at least in the reported cases IDH-1 negativ-
ity provides evidence that in their pathogenesis AGs 
differ from grade II astrocytomas, which in most cases 
harbor a mutation of IDH-1 [9].
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